-
Mashup Score: 0
International Primary Biliary Cholangitis Day, celebrated on September 10, aspires to raise awareness of the challenges that patients with this rare liver disease face and how their stories can help advance diagnosis, treatment and care. A relatively rare disease, both in the United States and worldwide, PBC affects an estimated 65 out of the 100,000 women in the U.S., according to the American
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0
The phase 3 seladelpar investigator discusses the current landscape of care available for patients with PBC.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
From the first part of our Q&A with @DrCynthiaLevy on the state of #PBC burden and treatment: what is the role of ALP management? Read here: https://t.co/DStFb3jxVX https://t.co/JFx53Nztju
-
-
Mashup Score: 0
In a Healio video exclusive, Andreas Kremer, MD, PhD, MHBA, highlights recent data on primary biliary cholangitis presented at EASL Congress, including risk factors for disease progression and seladelpar for treatment of pruritis.In a retrospective analysis, Kremer and colleagues examined 1,111 patients with primary biliary cholangitis (PBC) who received ursodeoxycholic acid as first-line
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
In a @GoHealio #GI video exclusive, Andreas Kremer, MD, PhD, MHBA, highlights recent data on #PBC presented at #EASLCongress ( @EASLnews), including risk factors for disease progression and #seladelpar for treatment of #pruritis. https://t.co/xcx1s22G94
-
-
Mashup Score: 7Managing Primary Biliary Cholangitis: An Expert Exchange - 2 year(s) ago
Are you optimally monitoring your patients with primary biliary cholangitis (PBC)?
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
Are you optimally monitoring your patients with primary biliary cholangitis? #PBC #CME #MedTwitter https://t.co/oOsrnPdSnu https://t.co/vclmCUJRgB
-
-
Mashup Score: 2Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes - 2 year(s) ago
We read with interest the work by Mansoor et al 1 regarding the outcomes of COVID-19 in coeliac disease. The impact of pre-existing chronic liver diseases on COVID-19 outcomes has been largely evaluated,2–4 and consequently specific recommendations have been made in these patients.5 However, the relationship between primary biliary cholangitis (PBC) and SARS-CoV-2 remains unknown.6 We aimed to…
Source: GutCategories: Gastroenterology, Latest HeadlinesTweet-
RT @joaprimo: Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes https://t.co/1PQNDHR2fU #PBC…
-
-
Mashup Score: 1Seladelpar effective, safe in PBC with cirrhosis - 3 year(s) ago
Treating patients who have primary biliary cholangitis and cirrhosis with seladelpar — a peroxisome proliferator-activated receptor agonist — led to improved liver biochemistries and improved pruritus scores, according to a presenter at the International Liver Congress. “The cirrhotics are obviously our most vulnerable population. These are the people who may be at risk of
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#Seladelpar effective, safe in #PBC with #cirrhosis @EASLnews #ILC2021 #MedTwitter https://t.co/CjUmGjdTyP
-
-
Mashup Score: 1
Background & Aims Liver fibrosis holds a relevant prognostic meaning in primary biliary cholangitis (PBC). Non-invasive fibrosis evaluation using vibration-controlled transient elastography (VCTE) i…
Source: AASLDCategories: Gastroenterology, Latest HeadlinesTweet-
VCTE with a dual cut-off approach can confirm or exclude fibrosis in more than 60% of patients with #PBC ✅ Cutoffs: </= 6.5kPa and > 11.0kPa ✅ Use at diagnosis when treatment naive ✅ Not affected by BMI or liver tests https://t.co/BVqujYgnk3 https://t.co/lmQYutlcbQ
-
-
Mashup Score: 0
Primary biliary cholangitis (PBC) is a chronic, inflammatory and cholestatic liver disease with a variable rate of progression towards biliary cirrhosis. Here, the authors discuss the current understanding of PBC pathogenesis and highlight implications for new therapies.
Categories: Gastroenterology, Latest HeadlinesTweet-
#TBT REVIEW | Primary biliary cholangitis: pathogenesis and therapeutic opportunities https://t.co/GvNJ9bK5J6 This Figure shows immune dysregulation in #PBC https://t.co/fybt3aPK8r
-
-
Mashup Score: 1
Robert Coleman, MD, FACOG, FACS, Chief Scientific Officer US Oncology Research discusses ASCO 2020 A phase III randomized controlled trial of secondary surgical cytoreduction (SSC) followed by platinum-based combination chemotherapy (PBC), with or without bevacizumab (B) in platinum-sensitive, recurrent ovarian cancer (PSOC): A NRG Oncology/Gynecologic Oncology Group (GOG) study. Context:…
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Phase III randomized controlled trial of secondary surgical cytoreduction - Robert Coleman, MD, FACOG, FACS @USOResearch @TheUSONetwork #ASCO20 #SSC #PBC #ovariancancer #oncology #clinicaltrial Link to FULL video: https://t.co/Ck4U5cUZtM https://t.co/D4rGOxseSW
-
-
Mashup Score: 1
Robert Coleman, MD, FACOG, FACS, Chief Scientific Officer US Oncology Research discusses ASCO 2020 A phase III randomized controlled trial of secondary surgical cytoreduction (SSC) followed by platinum-based combination chemotherapy (PBC), with or without bevacizumab (B) in platinum-sensitive, recurrent ovarian cancer (PSOC): A NRG Oncology/Gynecologic Oncology Group (GOG) study. Context:…
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Robert Coleman, MD, FACOG, FACS @USOResearch #ASCO20 #SSC #PBC #ovariancancer A phase III randomized controlled trial of secondary surgical cytoreduction https://t.co/zuJQuVGQfY https://t.co/9XY8Req3Q6
-
‘Ask me about #PBC’ campaign calls on patients to speak up for rare #liverdisease #InternationalPBCDay https://t.co/irmbWC2iCN